Floating Button
Home Capital Broker's Calls

Analysts unanimous on Grab’s improved prospects after 2QFY2023 outperformance

Bryan Wu
Bryan Wu • 4 min read
Analysts unanimous on Grab’s improved prospects after 2QFY2023 outperformance
Grab beat analysts' expectations for its 2QFY2023 ended June 30 and raised its full-year ebitda guidance. Photo: Albert Chua/The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts across the board are positive on Grab Holdings after the NASDAQ-listed company beat expectations for its 2QFY2023 ended June 30 and raised its full-year ebitda guidance. Citi Research, Maybank Research, HSBC Global Research and CGS-CIMB Research have each maintained their “buy” and “add” calls on Grab.

Citi analysts Alicia Yap, Nelson Cheung and Vicky Wei have raised their target prices to US$5.20 ($7.06) from US$4.80 previously, while Maybank’s Kelvin Tan has lifted his target price to $4.20 from $4.00 previously. Piyush Choudhary and Rishabh Dhancholia of HSBC and Ong Khang Chuen and Kenneth Tan of CGS-CIMB have held firm on their respective target prices of US$4.25 and US$4.50.

In their report dated Aug 24, the Citi analysts say that along with a “clean, solid 2QFY2023 beat”, and despite Grab’s management conservatively maintaining its FY2023 revenue guidance to the high-end of its 54% to 60% y-o-y improvement range, they are positive on the company’s substantial revision of its FY2023 group ebitda forecast to a loss of US$30 to US$40 million from a loss of US$195 million to US$235 million previously

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.